Employees: NN (None)Legal category: 5770Size: PMECreation date: 2022-03-21 (4 years)Status: ActiveBusiness sector: Fonds de placement et entités financières similairesLocation: MARSEILLE (13006), Bouches-du-Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SPFPLSAS DE MEDECINS DANVIN ISABELLE : revenue, balance sheet and financial ratios
SPFPLSAS DE MEDECINS DANVIN ISABELLE is a French company
founded 4 years ago,
specialized in the sector Fonds de placement et entités financières similaires.
Based in MARSEILLE (13006),
this company of category PME
shows in 2025 a net income positive of 145 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SPFPLSAS DE MEDECINS DANVIN ISABELLE (SIREN 912033545)
Indicator
2025
2024
Revenue
N/C
N/C
Net income
144 505 €
44 966 €
EBITDA
-1 939 €
-2 146 €
Net margin
N/C
N/C
Revenue and income statement
In 2025, SPFPLSAS DE MEDECINS DANVIN ISABELLE generates positive net income of 145 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2024-2025: 45 k€ -> 145 k€.
EBITDA (2025)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
-1 939 €
EBIT (2025)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-1 939 €
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
144 505 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 38%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.6 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
37.527%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
68.966%
Repayment capacity (2025)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.581
Solvency indicators evolution SPFPLSAS DE MEDECINS DANVIN ISABELLE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2024
2025
Debt ratio
93.037
37.527
Financial autonomy
51.804
68.966
Repayment capacity
2.745
0.581
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
37.532025
2024
2025
Q1: 0.14
Med: 27.24
Q3: 146.28
Average-17 pts over 2 years
In 2025, the debt ratio of SPFPLSAS DE MEDECINS DANV... (37.53) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
68.97%2025
2024
2025
Q1: 17.38%
Med: 54.75%
Q3: 87.41%
Good+13 pts over 2 years
In 2025, the financial autonomy of SPFPLSAS DE MEDECINS DANV... (69.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
0.58 years2025
2024
2025
Q1: 0.0 years
Med: 0.77 years
Q3: 6.12 years
Good-20 pts over 2 years
In 2025, the repayment capacity of SPFPLSAS DE MEDECINS DANV... (0.58) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 738.97. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
738.971
Interest coverage (2025)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
-52.14
Liquidity indicators evolution SPFPLSAS DE MEDECINS DANVIN ISABELLE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2024
2025
Liquidity ratio
None
738.971
Interest coverage
-62.535
-52.14
Sector positioning
Liquidity ratio
738.972025
2025
Q1: 159.67
Med: 1116.63
Q3: 6512.12
Average
In 2025, the liquidity ratio of SPFPLSAS DE MEDECINS DANV... (738.97) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
-52.14x2025
2024
2025
Q1: -191.54x
Med: -25.42x
Q3: 0.0x
Average+6 pts over 2 years
In 2025, the interest coverage of SPFPLSAS DE MEDECINS DANV... (-52.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Positioning of SPFPLSAS DE MEDECINS DANVIN ISABELLE in its sector
Comparison with sector Fonds de placement et entités financières similaires
Valuation estimate
Based on 170 transactions of similar company sales
(all years),
the value of SPFPLSAS DE MEDECINS DANVIN ISABELLE is estimated at
1 498 054 €
(range 928 576€ - 2 329 946€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
170 transactions
928k€1498k€2329k€
1 498 054 €Range: 928 576€ - 2 329 946€
NAF 5 all-time
Valuation method used
Net Income Multiple
144 505 €
×
10.4x
=1 498 055 €
Range: 928 576€ - 2 329 947€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 170 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Fonds de placement et entités financières similaires)
Compare SPFPLSAS DE MEDECINS DANVIN ISABELLE with other companies in the same sector:
Frequently asked questions about SPFPLSAS DE MEDECINS DANVIN ISABELLE
What is the revenue of SPFPLSAS DE MEDECINS DANVIN ISABELLE ?
The revenue of SPFPLSAS DE MEDECINS DANVIN ISABELLE is not publicly disclosed (confidential accounts filed with INPI).
Is SPFPLSAS DE MEDECINS DANVIN ISABELLE profitable?
Yes, SPFPLSAS DE MEDECINS DANVIN ISABELLE generated a net profit of 145 k€ in 2025.
Where is the headquarters of SPFPLSAS DE MEDECINS DANVIN ISABELLE ?
The headquarters of SPFPLSAS DE MEDECINS DANVIN ISABELLE is located in MARSEILLE (13006), in the department Bouches-du-Rhone.
Where to find the tax return of SPFPLSAS DE MEDECINS DANVIN ISABELLE ?
The tax return of SPFPLSAS DE MEDECINS DANVIN ISABELLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SPFPLSAS DE MEDECINS DANVIN ISABELLE operate?
SPFPLSAS DE MEDECINS DANVIN ISABELLE operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart